IV (intravenous) therapy involves delivering fluids, medications, vitamins, and essential nutrients directly into your bloodstream, allowing for rapid and efficient absorption that bypasses the digestive system
The study, along with prior research and cardiovascular trials, suggests that GLP1 receptor agonists may offer a broad survival benefit through combined cardiometabolic and cellular effects
Linkova, N
[email protected] #RealWorldEvidence #RWE #RealWorldData #MedicalAffairs #Pharma #LifeSciences #HealthcareInnovation #PatientOutcomes #EvidenceGeneration #MedicalScienceLiaison #HCPEngagement #PharmaceuticalIndustry To view or add a comment, sign in With approximately 7,000 rare diseases identifiedand fewer than 10% having approved treatmentsnew approaches to evidence generation are critical
Serious or Less Common Side Effects Although rare, more serious side effects can occur
Unintentional weight loss : Beyond expected therapeutic weight reduction, or inability to maintain adequate nutrition
